Aukelso
Denosumab-kyqq · Biocon Biologics Inc.
PRESCRIPTION ONLY (USA)Aukelso ingredients
| Active ingredient | Strength |
|---|---|
| Denosumab | 120 mg/1.7mL |
What Aukelso is used for
Aukelso is a specialist medicine (rank ligand inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Aukelso
- Generic name
- Denosumab-kyqq
- Made by
- Biocon Biologics Inc.
- Forms
- Injection
- Given
- Subcutaneous
- Drug class
- RANK Ligand Inhibitor
- FDA approval
- Biologic licence (BLA) BLA761436
- On the US market since
- 2026
Official information
- Aukelso prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Denosumab-kyqq)
In India
- Denosumab: 11 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Aukelso?
Aukelso (Denosumab-kyqq) is a specialist medicine made by Biocon Biologics Inc., approved by the US FDA.
What are the ingredients of Aukelso?
Aukelso contains Denosumab (120 mg/1.7mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA